MeiraGTx Holdings PLC (MGTX)
6.48
-0.16
(-2.41%)
USD |
NASDAQ |
Nov 15, 16:00
6.48
0.00 (0.00%)
After-Hours: 17:32
MeiraGTx Holdings Profit Margin (Quarterly): -17.24K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -17.24K% |
March 31, 2024 | -2.93K% |
December 31, 2023 | |
September 30, 2023 | -868.1% |
June 30, 2023 | -835.6% |
March 31, 2023 | -910.7% |
December 31, 2022 | |
September 30, 2022 | -774.2% |
June 30, 2022 | -315.8% |
March 31, 2022 | -551.1% |
December 31, 2021 | -47.10% |
Date | Value |
---|---|
September 30, 2021 | -373.4% |
June 30, 2021 | -392.6% |
March 31, 2021 | -514.0% |
December 31, 2020 | -276.2% |
September 30, 2020 | -126.3% |
June 30, 2020 | -1.03K% |
March 31, 2020 | -372.5% |
December 31, 2019 | -78.95% |
September 30, 2019 | -292.0% |
June 30, 2019 | -1.05K% |
March 31, 2019 | -2.29K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.24K%
Minimum
Jun 2024
-47.10%
Maximum
Dec 2021
-1.63K%
Average
-514.0%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
Heron Therapeutics Inc | -25.64% |
Harmony Biosciences Holdings Inc | 24.78% |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -3.67K% |
IGC Pharma Inc | -874.3% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -83.86% |
Return on Assets | -31.47% |
Return on Invested Capital | -50.85% |
Operating Margin (Quarterly) | -16.28K% |
Return on Net Operating Assets | -50.29% |